Intellia Therapeutics, a biopharmaceutical company specializing in CRISPR gene editing, announced its participation in three upcoming investor conferences: Bank of America Securities Health Care Conference on May 12, RBC Capital Markets Global Healthcare Conference on May 20, and Jefferies Global Healthcare Conference on June 3, 2026. The company's management will engage in fireside chats at these events, which will be webcast live and available for replay. This participation highlights Intellia's ongoing efforts to engage with investors and showcase its advancements in gene editing technology and clinical development.
Sierra Bancorp reported Q2 earnings per share (EPS) of $0.77, below analyst expectations of $0.89, and revenue of $38.98 million, missing the forecast of $39.59 million. The EPS slightly declined from $0.78 a year ago, indicating a small year-over-ye...
Navitas Semiconductor, a maker of AI data center power chips, has seen its stock fall 40% this month, making its upcoming earnings report crucial. Analysts expect a loss of $0.04 per share and revenue near $10 million, reflecting a 31.3% decline from...
Michelin has published its financial report for the first half of 2026, which is now accessible on its official website. The report has also been officially filed with the French Autorité des Marchés Financiers (AMF), ensuring regulatory compliance. ...
Michelin has published and filed its half-year financial report as of June 30, 2026, with the French financial regulator AMF. The report and the presentation of the 2026 half-year results are accessible on Michelin's official website. This disclosure...
In the first half of 2026, Michelin saw an increase in segment operating income at constant scope and exchange rates, alongside a rise in free cash flow before mergers and acquisitions. The company has confirmed its financial guidance for the full ye...
